PM

Priyanka Mishra

Active Director Director DIN 10639172
DIN 10639172 First appointment May 2024 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Priyanka Mishra

Data last updated:

Priyanka Mishra is a Director at Mtas Pharmaceuticals Private Limited (since 2024). The company operates in Pharma.

DIN 10639172
Primary Designation Director
Industry Pharma
First Appointment 22 May 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Mtas Pharmaceuticals Private Limited U47721DL2024PTC431660
Director22 May 20242024Active

Board colleagues of Priyanka Mishra

Directorship timeline

Open interactive timeline →
Mtas Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Priyanka Mishra

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Priyanka Mishra

Priyanka Mishra currently holds 1 directorship: Mtas Pharmaceuticals Private Limited (Director, since 22 May 2024).

Priyanka Mishra was first appointed on 22 May 2024 as Director at Mtas Pharmaceuticals Private Limited.

The current boards of Priyanka Mishra's companies include Anjum Prawez (Mtas Pharmaceuticals Private Limited), Mohammad Tarique (Mtas Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available